Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain inhibitory neurons; strongest in adrenal medulla cells | 0.75 |
| chemistry Open Targets | compounds already reach it: frovatriptan succinate, almotriptan malate, elzasonan +21 | 1.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 349 | 0.79 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 9977
Sealed predictions
- HTR1B in dopamine neurons, braakn/a → n/areceipt 9984
Swarm cases
receipt 9984: HTR1B in dopamine neurons, braak
- cell type
- HTR1B is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for HTR1B in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts